News

Protagen’s Cancer Immunotherapy Array will be used to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors
| 2 min read

Protagen’s Cancer Immunotherapy Array will be used to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors